Two Decades of Ecstasy: Shifting Demographic Trends in Decedents using MDMA

Patil Armenian1, Luke N Rodda2,3

  • 1Emergency Medicine and Medical Toxicology, Department of Emergency Medicine, University of California, San Francisco - Fresno, 155 N Fresno St, Fresno, California, United States.

Insights

Deaths involving 3,4-Methylenedioxymethamphetamine (MDMA) shifted from predominantly young Black males in homicides to White males in accidental polydrug deaths over 20 years in San Francisco.

Area of Science:

  • Forensic Toxicology
  • Public Health
  • Demographic Studies

Background:

  • 3,4-Methylenedioxymethamphetamine (MDMA), a party drug, has been increasingly detected in post-mortem toxicology.
  • Understanding demographic trends in MDMA-related deaths is crucial for public health interventions.

Purpose of the Study:

  • To analyze demographic shifts and trends in deaths involving MDMA in San Francisco from 2000-2019.
  • To identify changes in the manner of death and associated factors over two decades.

Main Methods:

  • Retrospective analysis of 148 death cases with positive MDMA toxicology findings in San Francisco (2000-2019).
  • Data extraction included demographics, manner of death, cause of death, and MDMA concentrations.
  • Comparison of trends between the first (2000-2009) and second (2010-2019) decades of the study period.

Main Results:

  • Males constituted 87.2% of cases, with homicide and accidental deaths being most common.
  • Black males predominated homicide deaths (88.1%), often due to gunshot wounds, particularly in the first decade.
  • Accidental deaths, primarily among White males and often involving polydrug use, increased in the second decade.

Conclusions:

  • MDMA-related deaths have shown a significant demographic shift over 20 years.
  • The drug's association has evolved from primarily violent homicides to accidental polydrug-related fatalities.
  • Findings highlight the changing patterns of MDMA use and its diverse socio-economic associations.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
102
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
115
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
93
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
449
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
101
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
560